CGD Policy Blogs
When Bill Clinton says something about anything, people listen. So the former President's recent endorsement of mandatory HIV testing and even compulsory disclosure in high prevalence countries has, without a doubt, fuelled the ongoing debate about mandatory vs. opt-out testing. A recent article in the Financial Times highlights some of the arguments and outlines Clinton's justification for his support of mandatory testing:
Ten thousand people, mainly children, will die around the world today from a vaccine-preventable disease.
According to an article in BBC News, researchers from Johns Hopkins University working on the Rakai Project in Uganda have released two important findings: that there are multiple subtypes of HIV/AIDS in the community (sub-types A and D are the most common in Uganda), and that the different subtypes have different viral progressions in infected people:
In a recent interview with Reuters Newswire, Richard Feachem, the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria complained that donors have not committed sufficient resources for the Global Fund to meet its obligations for on-going programs in poor countries:
The second edition of the Disease Control Priorities Project was launched earlier this week. Though full of important cost-effectiveness studies of major developing country diseases, the 1400-page tome is not quite what youâ€™d expect to find in the hands of a busy policymaker or priority-setter.
The Wall Street Journal (subscription required) covered the increasing - and disturbing - phenomenon of South African AIDS patients who deliberately discontinue their free antiretroviral treatment in order to qualify for government-funded disability payments, which typically depend on a dangerously low CD4 count.